Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

Form 6-K

 

 

 

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

 

For the month of November, 2023

 

Commission File Number: 001-41106

 

 

 

Incannex Healthcare Limited

(Exact name of Registrant as specified in its charter)

 

 

 

not applicable

(Translation of Registrant’s name into English)

 

Australia

(Jurisdiction of incorporation or organization)

 

Joel Latham

Chief Executive Officer and Managing Director

Level 39, Rialto South Tower
525 Collins Street

Melbourne 3000

Australia

(Address of principal executive offices)

 

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F:

 

Form 20-F ☒ Form 40-F ☐

 

 

 

 

 

INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K

 

On November 17, 2023, The Australian Securities Exchange filed an announcement captioned: “Suspension from Official Quotation”, a copy of which announcement is attached to this Form 6-K as Exhibit 99.1.

 

1

 

Signatures

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

	Incannex Healthcare Limited
Date: November 17, 2023	By:	/s/ Joel Latham
	Name:	Joel Latham
	Title:	Chief Executive Officer and Managing Director

 

2

 

INDEX TO EXHIBITS

 

Exhibit No.
99.1		ASX Announcement, dated November 17, 2023 - Suspension from Official Quotation

 

 

3

 

 

Exhibit 99.1

 

 

Market Announcement

 

17 November 2023

 

 

Incannex Healthcare Limited (ASX: IHL) – Suspension from Quotation

 

Description

 

The securities of Incannex Healthcare Limited (‘IHL’) will be suspended from quotation at the close of trading on Friday, 17 November 2023 under Listing Rule 17.2, following lodgement of the Federal Court of Australia orders with ASIC approving the scheme of arrangement by which Incannex Healthcare Inc. will acquire all of the issued securities in IHL.

 

Issued by

 

Melissa Kostopoulos

Senior Adviser, Listings Compliance

 

 

17 November 2023		Market Announcement 1/1
ASX Limited		ASX Customer Service Centre 131 279 | asx.com.au

---